Reaction

Attention Deficit/Hyperactivity Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,230 reports · 73 co-occurring drugs

As of the last recalculation, Attention Deficit/Hyperactivity Disorder appears in 3,230 FAERS reports alongside 73 co-occurring drug terms. The strongest observed disproportionality signal is ATOMOXETINE HYDROCHLORIDE (PRR 42.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Atomoxetine Hydrochloride	150	42.5	42.8
Methylphenidate Hydrochloride	278	33.0	33.1
Guanfacine	32	26.5	26.6
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	113	21.3	21.4
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	126	20.3	20.4
Lisdexamfetamine Dimesylate	91	18.3	18.3
Divalproex Sodium	89	12.6	12.7
Methylphenidate	55	12.4	12.5
Valproate Sodium	38	12.0	12.0
Valproic Acid	55	11.4	11.4
Etonogestrel And Ethinyl Estradiol	37	10.9	10.9
Paroxetine Hydrochloride	133	9.8	9.8
Sodium Oxybate	88	8.8	8.8
Amphetamine	11	8.6	8.6
Lamotirigine	92	8.5	8.5
Lamotrigine Extended-Release	92	8.5	8.5
Lamotrigine Chewable Dispersible	92	8.5	8.5
Finasteride	75	8.2	8.2
Lamotrigine	158	8.1	8.1
Modafinil	40	8.1	8.1
Ampicillin	10	7.8	7.8
Ampicillin Sodium	10	7.8	7.8
Armodafinil	25	7.7	7.7
Sertraline Hydrochloride	136	7.7	7.7
Bupropion Hydrochloride	109	7.3	7.3
Montelukast Sodium	132	7.2	7.2
Fluoxetine Hydrochloride	134	7.0	7.0
Isotretinoin	53	7.0	7.0
Ziprasidone Mesylate	15	6.8	6.8
Buprenorphine Hydrochloride, Naloxone Hydrochloride	25	6.7	6.7
Ziprasidone	18	6.6	6.6
Carbamazepine	66	6.5	6.5
Lithium	24	6.2	6.2
Lithium Bromatum	24	6.2	6.2
Carisoprodol	18	6.1	6.1
Quetiapine	171	6.0	6.0
Oxcarbazepine	29	5.8	5.8
Clonidine	45	5.7	5.7
Topiramate	81	5.7	5.7
Venlafaxine Hydrochloride	112	5.6	5.6
Olanzapine Pamoate	33	5.2	5.2
Aripiprazole	97	5.2	5.2
Risperidone	100	5.0	5.0
Lithium Carbonate	13	4.9	5.0
Clonazepam	117	4.8	4.8
Ciprofloxacin Hydrochloride And Hydrocortisone	15	4.7	4.7
Varenicline Tartrate	57	4.7	4.7
Desvenlafaxine Succinate	19	4.6	4.6
Dicyclomine Hydrochloride	10	4.5	4.5
Asfotase Alfa	7	4.5	4.5
Nevirapine	6	4.3	4.3
Ethyl Alcohol	17	4.0	4.1
Misoprostol	6	4.0	4.0
Drospirenone And Ethinyl Estradiol	27	4.0	4.0
Polyethylene Glycol 3350	57	3.9	3.9
Eszopiclone	15	3.8	3.8
Vortioxetine	10	3.8	3.8
Isopropyl Alcohol	19	3.6	3.6
Iron Sucrose	5	3.4	3.4
Multivitamin	26	3.4	3.4
Amantadine	8	3.3	3.3
Lurasidone Hydrochloride	10	3.1	3.1
Somatropin	34	3.0	3.0
Asenapine Maleate	4	3.0	3.0
Tobramycin	11	3.0	3.0
Alcohol	17	2.8	2.8
Vilazodone Hydrochloride	4	2.8	2.8
Naltrexone	9	1.9	1.9
Paliperidone Palmitate	9	1.8	1.8
Paliperidone	6	1.7	1.7
Vigabatrin	3	1.3	1.3
Etonogestrel	5	0.7	0.7
Copper	4	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.